Send us a text

Substance use disorder affects millions, yet less than 10% receive treatment. In this episode of CareTalk, John Driscoll speaks with Dr. Yusuf Sherwani, CEO and Co-Founder of Pelago, about a new approach to addiction care. They explore how Pelago is using virtual treatment, data, and value-based care to break down barriers like stigma, access, and cost—reshaping how we treat one of healthcare’s most persistent challenges.


🎙️⚕️ABOUT DR. YUSUF SHERWANI
Yusuf is the Co-Founder and CEO at Pelago, the leading digital clinic for substance use management. He is a Londoner living in New York City.

He likes to back hungry, foolish and humble founders. Occasionally angel investing in category defining companies, with a healthcare bias, including: Curebase, Healthie, Levels, firsthand, Mytos, Finni Health, Anterior, Replit, Safi, Mercury, Sequence and others. 

Previously he bootstrapped two startups (1 modest exit, 1 failed). He was born and brought up in London, UK and studied Medicine (MD) and Management (BSc) at Imperial College London. In 2019, he was named one of Fast Company’s Most Creative Business People and Forbes’ 30 Under 30 entrepreneurs.

🎙️⚕️ABOUT CARETALK
CareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. 

GET IN TOUCH
Follow CareTalk on LinkedIn
Become a CareTalk sponsor
Guest appearance requests
Visit us on the web
Subscribe to the CareTalk Newsletter

Support the show

⚙️CareTalk: Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.